
POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price?
SAN DIEGO, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Stakeholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma Global, Inc. ("POINT") (NASDAQ: PNT) breached their fiduciary duties in …